I have taken 3 mg of Lunesta for a year. A wonderful sleep aid with no psychomotor or memory impairment.
FDA Halves Initial Dose for Lunesta — Physician’s First Watch
FDA Halves Initial Dose for Lunesta
By Kelly Young
The FDA has recommended that the starting dose of the sleep drug eszopiclone (Lunesta) be lowered from 2 mg to 1 mg after a study found that patients taking higher doses were at increased risk for severe psychomotor and memory impairment the next morning.
The agency noted that the dose can be increased to 2 mg or 3 mg as needed, but it cautions people who take 3 mg against driving or doing other activities that require their full attention the next day.
A study of roughly 90 adults found that 3 mg of eszopiclone was linked to severe psychomotor and memory impairment 7.5 hours after taking the drug. Problems with driving, memory, and coordination can occur more than 11 hours after taking the evening dose.
The FDA is evaluating all sleep aid drugs for the potential to affect next-day mental alertness. It already required lowering Ambien doses over similar concerns.